Aripiprazole lauroxil (US brand name Aristada Initio®) is a second-generation (“atypical”) antipsychotic.
On this page, we present some basic information about this medication. Other articles on this website with more advanced information and tips related to this medication are linked to under Related Pages below.
Aristada Initio®, given in combination with oral aripiprazole, is indicated for the initiation of Aristada® (long-acting IM monthly injection of aripiprazole lauroxil) for the treatment of schizophrenia in adults.
Aristada Initio® may also be given for re-starting Aristada® after a missed dose.
One 675 mg injection of Aristada Initio® is administered intramuscularly with 30 mg of oral aripiprazole in conjunction with first dose of Aristada®.
Note: Aristada Initio® should be given only as a single dose and is not indicated for repeat dosing. It should be given as an intramuscular injection in the deltoid or gluteal muscle and NOT as an intravenous injection.
Dosage forms and strengths
Extended-release injectable suspension: 675 mg single-dose pre-filled syringe
Important! Please refer to the full Prescribing Information (see link below) before prescribing this medication.
Copyright © 2018 to 2021, Simple and Practical Medical Education, LLC. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.